These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 29588800)
1. Meeting the Unmet - The Cre8 Polymer-free Drug-eluting Stents Technology: Proceedings of a satellite symposium held at EuroPCR on May 20th - 23rd 2014 in Paris. Mountfort K; Carrié D; Valgimigli M; Sardella G; Banai S; Romaguera R; Stella P Interv Cardiol; 2014 Aug; 9(3):184-189. PubMed ID: 29588800 [TBL] [Abstract][Full Text] [Related]
2. Cre8™ Unique Technology in Challenging Daily Practice: Proceedings of a satellite symposium held at EuroPCR on 20th - 23rd May 2014 in Paris. Mountfort K; Antoniucci D; Mehran R; DeLuca G; Nef H; Vrolix M; Khashaba A Interv Cardiol; 2014 Aug; 9(3):180-183. PubMed ID: 29588799 [TBL] [Abstract][Full Text] [Related]
3. The use of the Cre8 Stent in Patients With Diabetes Mellitus. Carrié D Interv Cardiol; 2016 May; 11(1):47-50. PubMed ID: 29588705 [TBL] [Abstract][Full Text] [Related]
4. A multicenter randomized trial comparing amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesions. Carrié D; Berland J; Verheye S; Hauptmann KE; Vrolix M; Violini R; Dibie A; Berti S; Maupas E; Antoniucci D; Schofer J J Am Coll Cardiol; 2012 Apr; 59(15):1371-6. PubMed ID: 22284328 [TBL] [Abstract][Full Text] [Related]
5. Patient-tailored Drug-eluting Stent Choice - A Solution for Patients with Diabetes: Proceedings of Two Satellite Symposia Held at EuroPCR in May 2015 in Paris. Mountfort K; Mehran R; Colombo A; Stella P; Romaguera R; Sardella G Interv Cardiol; 2015 Sep; 10(3):158-161. PubMed ID: 29588695 [TBL] [Abstract][Full Text] [Related]
6. Cre8™ coronary stent: preclinical in vivo assessment of a new generation polymer-free DES with Amphilimus™ formulation. Moretti C; Lolli V; Perona G; Vignolini MC; Cabiale K; Falzone M; Galloni M EuroIntervention; 2012 Jan; 7(9):1087-94. PubMed ID: 22130128 [TBL] [Abstract][Full Text] [Related]
7. Randomized comparison between 3-month Cre8 DES vs. 1-month Vision/Multilink8 BMS neointimal coverage assessed by OCT evaluation: the DEMONSTRATE study. Prati F; Romagnoli E; Valgimigli M; Burzotta F; De Benedictis M; Ramondo A; Mehran R; Stella PR Int J Cardiol; 2014 Oct; 176(3):904-9. PubMed ID: 25171966 [TBL] [Abstract][Full Text] [Related]
8. Advances with polymer-free amphilimus-eluting stents. CARRIé D Minerva Cardioangiol; 2016 Jun; 64(3):339-53. PubMed ID: 26934663 [TBL] [Abstract][Full Text] [Related]
9. Cre8 Drug Eluting Stent Performance in Daily Cardiology Practice. Sinan UY; Serin E; Keskin-Meric B; Arat-Ozkan A Rev Cardiovasc Med; 2023 Feb; 24(2):53. PubMed ID: 39077417 [TBL] [Abstract][Full Text] [Related]
10. Vulnerable struts with CRE8, Biomatrix and Xience stents assessed with OCT and their correlation with clinical variables at 6-month follow-up: the CREBX-OCT study. Giglioli C; Formentini C; Romano SM; Cecchi E; Baldereschi GJ; Landi D; Chiostri M; Prati F; Marchionni N Int J Cardiovasc Imaging; 2020 Feb; 36(2):217-230. PubMed ID: 31667661 [TBL] [Abstract][Full Text] [Related]
11. PCI in Patients with Diabetes: Role of the Cre8 Drug-eluting Stent. Byrne RA; Eeckhout E; Sardella G; Stella P; Verheye S Interv Cardiol; 2017 May; 12(1):13-17. PubMed ID: 29588724 [TBL] [Abstract][Full Text] [Related]
12. Stent thrombosis with drug-eluting stents: is the paradigm shifting? Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Genereux P; Branzi A; Stone GW J Am Coll Cardiol; 2013 Nov; 62(21):1915-1921. PubMed ID: 24036025 [TBL] [Abstract][Full Text] [Related]
13. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent. Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925 [TBL] [Abstract][Full Text] [Related]
14. The Cre8 amphilimus-eluting stent for the treatment of coronary artery disease: safety and efficacy profile. Pivato CA; Leone PP; Petriello G; Sanz-Sanchez J; Chiarito M; Stefanini GG Expert Rev Med Devices; 2020 Apr; 17(4):267-275. PubMed ID: 32151183 [No Abstract] [Full Text] [Related]
15. Absorbable Polymer Technology - Viable Solutions for Unmet Needs in PCI: Proceedings of two satellite symposia held at EuroPCR, Paris in May 2015. Mountfort K; Khashaba A; Garbo R; Tigen K; Moellmann H; Morice MC Interv Cardiol; 2015 Sep; 10(3):162-166. PubMed ID: 29588696 [TBL] [Abstract][Full Text] [Related]
16. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries). Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443 [TBL] [Abstract][Full Text] [Related]
17. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis. El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402 [TBL] [Abstract][Full Text] [Related]
18. Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy. Kereiakes DJ; Yeh RW; Massaro JM; Driscoll-Shempp P; Cutlip DE; Steg PG; Gershlick AH; Darius H; Meredith IT; Ormiston J; Tanguay JF; Windecker S; Garratt KN; Kandzari DE; Lee DP; Simon DI; Iancu AC; Trebacz J; Mauri L; JACC Cardiovasc Interv; 2015 Oct; 8(12):1552-62. PubMed ID: 26493248 [TBL] [Abstract][Full Text] [Related]